Related Experiment Videos
Experimental models of Reye's syndrome
A S Saratikov1, A I Vengerovskii, A G Arbuzov
1Department of Pharmacology, Medico-Biological Faculty, Siberian Medical University, Tomsk.
Bulletin of Experimental Biology and Medicine
|September 8, 2000
Summary
Rats treated with 4-pentenoic acid or acetylsalicylic acid developed metabolic disruptions and liver damage mirroring Reye
Area of Science:
- Biochemistry
- Toxicology
- Pathology
Background:
- Reye's syndrome is a severe condition affecting children and adolescents.
- Its exact cause remains unclear, but it is often associated with viral infections and aspirin use.
- Understanding induced models is crucial for research.
Purpose of the Study:
- To investigate the potential of 4-pentenoic acid and acetylsalicylic acid in inducing Reye's syndrome-like metabolic and hepatic changes in rats.
- To establish an animal model for studying Reye's syndrome pathogenesis.
Main Methods:
- Intraperitoneal administration of 4-pentenoic acid to rats at specific dosages and intervals.
- Administration of acetylsalicylic acid to rats following pyrogenal injection.
- Monitoring of various biochemical parameters and liver histology.
Main Results:
- Both 4-pentenoic acid and acetylsalicylic acid treatments induced significant metabolic disorders in rats.
- Observed changes included hyperenzymemia, hyperbilirubinemia, hypoglycemia, acidosis, and altered levels of urea and ketone bodies.
- Liver examination revealed characteristic pathological findings such as necroses and microvesicular steatosis.
Conclusions:
- 4-pentenoic acid and acetylsalicylic acid can effectively reproduce key metabolic and hepatic features of Reye's syndrome in a rat model.
- This model provides a valuable tool for further investigation into the mechanisms underlying Reye's syndrome.